Kimelman Baird buys $26.4 Million stake in Cantel Medical Corp. (CMN)

Cantel Medical Corp. (CMN) : Kimelman Baird scooped up 7,074 additional shares in Cantel Medical Corp. during the most recent quarter end , the firm said in a disclosure report filed with the SEC on May 13, 2016. The investment management firm now holds a total of 399,811 shares of Cantel Medical Corp. which is valued at $26.4 Million.Cantel Medical Corp. makes up approximately 4.90% of Kimelman Baird’s portfolio.

Other Hedge Funds, Including , State Of Tennessee Treasury Department boosted its stake in CMN in the latest quarter, The investment management firm added 664 additional shares and now holds a total of 28,164 shares of Cantel Medical Corp. which is valued at $1.9 Million. Cantel Medical Corp. makes up approx 0.01% of State Of Tennessee Treasury Department’s portfolio.Janney Montgomery Scott reduced its stake in CMN by selling 5,012 shares or 53.74% in the most recent quarter. The Hedge Fund company now holds 4,314 shares of CMN which is valued at $285,371. Cantel Medical Corp. makes up approx 0.01% of Janney Montgomery Scott’s portfolio.New York State Common Retirement Fund reduced its stake in CMN by selling 154,619 shares or 11.99% in the most recent quarter. The Hedge Fund company now holds 1,134,575 shares of CMN which is valued at $75.3 Million. Cantel Medical Corp. makes up approx 0.12% of New York State Common Retirement Fund’s portfolio.Proshare Advisors reduced its stake in CMN by selling 862 shares or 14.64% in the most recent quarter. The Hedge Fund company now holds 5,026 shares of CMN which is valued at $333,777.

Cantel Medical Corp. closed down -1.4 points or -2.08% at $65.79 with 1,60,294 shares getting traded on Wednesday. Post opening the session at $67.55, the shares hit an intraday low of $65.38 and an intraday high of $67.55 and the price fluctuated in this range throughout the day.Shares ended Wednesday session in Red.

On the company’s financial health, Cantel Medical Corp. reported $0.42 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on Mar 10, 2016. Analyst had a consensus of $0.39. The company had revenue of $158.30 million for the quarter, compared to analysts expectations of $154.51 million. The company’s revenue was up 16.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.36 EPS.

Cantel Medical Corp. is a provider of infection prevention and control products and services in the healthcare market. The Company’s segments include Endoscopy Water Purification and Filtration Healthcare Disposables Dialysis and Specialty Packaging. Its Endoscopy segment includes medical device reprocessing systems disinfectants detergents and other supplies. The Company’s Water Purification and Filtration segment includes water purification equipment and services filtration and separation products and disinfectants sterilization and decontamination products and services. Its Healthcare Disposables segment includes single-use infection prevention and control healthcare products. The Company’s Dialysis segment includes medical device reprocessing systems sterilants/disinfectants and dialysate concentrates. Its Specialty Packaging segment includes specialty packaging and thermal control products as well as related compliance training.

Leave a Reply

Cantel Medical Corp. - Is it time to Sell?

Top Brokerage Firms are advising their investors on Cantel Medical Corp.. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.